Si Yu Shen
Direktor/Vorstandsmitglied bei SINOTHERAPEUTICS INC.
Profil
Si Yu Shen is currently a Director at Shanghai United Imaging Healthcare Co., Ltd., Shanghai Phoebus Medical Technology Co., Ltd., and Sinotherapeutics,.
Inc. Shen received an undergraduate degree from Shanghai Jiao Tong University in 2004 and a doctorate degree from Fudan University in 2012.
Aktive Positionen von Si Yu Shen
Unternehmen | Position | Beginn |
---|---|---|
SINOTHERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.09.2018 |
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. | Direktor/Vorstandsmitglied | 09.10.2021 |
Shanghai Phoebus Medical Technology Co., Ltd.
Shanghai Phoebus Medical Technology Co., Ltd. Medical DistributorsDistribution Services Shanghai Phoebus Medical Technology Co., Ltd. is a provider of chronic disease management solutions, with a focus on monitoring diabetic retinopathy. The company is based in Shanghai, China. The Chinese company uses data to promote collaboration between medical institutions and offers comprehensive services for screening, monitoring, education, and follow-up to help reduce the risk of complications for diabetes and hypertension patients. The company was founded by Yun Wang. | Direktor/Vorstandsmitglied | 01.05.2019 |
Ausbildung von Si Yu Shen
Fudan University | Doctorate Degree |
Shanghai Jiao Tong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SINOTHERAPEUTICS INC. | Health Technology |
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. | Commercial Services |
Private Unternehmen | 1 |
---|---|
Shanghai Phoebus Medical Technology Co., Ltd.
Shanghai Phoebus Medical Technology Co., Ltd. Medical DistributorsDistribution Services Shanghai Phoebus Medical Technology Co., Ltd. is a provider of chronic disease management solutions, with a focus on monitoring diabetic retinopathy. The company is based in Shanghai, China. The Chinese company uses data to promote collaboration between medical institutions and offers comprehensive services for screening, monitoring, education, and follow-up to help reduce the risk of complications for diabetes and hypertension patients. The company was founded by Yun Wang. | Distribution Services |